These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24066462)

  • 21. [Treatment of hepatitis C. Different modalities based on viral genotype].
    Pariente A
    Rev Prat; 2003 Jun; 53(11):1175-6. PubMed ID: 15185639
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapy of hepatitis C in patients with HIV infection.
    Daugherty T; Bonacini M
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):375-84. PubMed ID: 15954854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment for hepatitis C in patients infected with human immunodeficiency virus.
    Fernández I; Muñoz R; Solís-Herruzo JA
    Rev Esp Enferm Dig; 2003 Apr; 95(4):287-91, 282-6. PubMed ID: 12826005
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacogenomics of hepatitis C and decision analysis: a glimpse into the future.
    Wong JB
    Hepatology; 2002 Jul; 36(1):252-4. PubMed ID: 12085373
    [No Abstract]   [Full Text] [Related]  

  • 25. Infection fighters. Hepatitis C and HIV.
    TreatmentUpdate; 2005; 17(1):7. PubMed ID: 17225318
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacology Update for the Treatment of Hepatitis C Virus.
    Hopkins L; Dunlap T; Cline H
    Nurs Clin North Am; 2020 Sep; 55(3):347-359. PubMed ID: 32762855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceuticals. Advocates protest the cost of a hepatitis C cure.
    Cohen J
    Science; 2013 Dec; 342(6164):1302-3. PubMed ID: 24337268
    [No Abstract]   [Full Text] [Related]  

  • 28. National Institutes of Health Consensus Development Conference statement Management of Hepatitis C: 2002 June 10-12, 2002.
    HIV Clin Trials; 2003; 4(1):55-75. PubMed ID: 12577198
    [No Abstract]   [Full Text] [Related]  

  • 29. Treating patients with HCV genotype 1 and low viraemia: more than meets the eye.
    Craxì A; Cammà C
    J Hepatol; 2006 Jan; 44(1):4-7. PubMed ID: 16293337
    [No Abstract]   [Full Text] [Related]  

  • 30. Sequence and phenotypic analysis for resistance monitoring in hepatitis C virus drug development: recommendations from the HCV DRAG.
    Kwong AD; Najera I; Bechtel J; Bowden S; Fitzgibbon J; Harrington P; Kempf D; Kieffer TL; Koletzki D; Kukolj G; Lim S; Pilot-Matias T; Lin K; Mani N; Mo H; O'Rear J; Otto M; Parkin N; Pawlotsky JM; Petropoulos C; Picchio G; Ralston R; Reeves JD; Schooley RT; Seiwert S; Standring D; Stuyver L; Sullivan J; Miller V; ; ; ;
    Gastroenterology; 2011 Mar; 140(3):755-60. PubMed ID: 21255574
    [No Abstract]   [Full Text] [Related]  

  • 31. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
    ; McCaughan GW; Omata M; Amarapurkar D; Bowden S; Chow WC; Chutaputti A; Dore G; Gane E; Guan R; Hamid SS; Hardikar W; Hui CK; Jafri W; Jia JD; Lai MY; Wei L; Leung N; Piratvisuth T; Sarin S; Sollano J; Tateishi R
    J Gastroenterol Hepatol; 2007 May; 22(5):615-33. PubMed ID: 17444847
    [No Abstract]   [Full Text] [Related]  

  • 32. Barriers to antiviral treatment in hepatitis C infected intravenous drug users.
    Gazdag G; Horvath G; Szabo O; Ungvari GS
    Neuropsychopharmacol Hung; 2010 Dec; 12(4):459-62. PubMed ID: 21220790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C and general practice: the challenge continues.
    Kidd M
    Aust Fam Physician; 2003 Oct; 32(10):795. PubMed ID: 14596072
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis C: changing genotype distribution with important implications for patient management.
    van Soest H; Boland GJ; van Erpecum KJ
    Neth J Med; 2006 Apr; 64(4):96-9. PubMed ID: 16609154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The challenge of hepatitis C and HIV co-infection.
    Carriero DC; Lucas J; Freemantle H; Dieterich DT
    Body Posit; 2005; 18(1):8-12, 15-7. PubMed ID: 16193566
    [No Abstract]   [Full Text] [Related]  

  • 36. Recommendation for treatment of hepatitis C virus infection.
    Kaymakoğlu S; Köksal İ; Tabak F; Akarca US; Akbulut A; Akyüz F; Bodur H; Çağatay A; Dinçer D; Esen Ş; Güner R; Gürel S; Köse Ş; Şentürk Ö; Şimşek H; Yamazhan T; Yılmaz Y; Idilman R; Guidelines Study Group VH
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 2):94-100. PubMed ID: 29303106
    [No Abstract]   [Full Text] [Related]  

  • 37. Current therapy of hepatitis C.
    de Knegt RJ
    Scand J Gastroenterol Suppl; 2006; (243):65-9. PubMed ID: 16782624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges and successes in developing new therapies for hepatitis C.
    De Francesco R; Migliaccio G
    Nature; 2005 Aug; 436(7053):953-60. PubMed ID: 16107835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment choice of the antiviral agent for the hepatitis C].
    Karino Y
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():269-73. PubMed ID: 26845943
    [No Abstract]   [Full Text] [Related]  

  • 40. [Argentine consensus on hepatitis C 2013].
    Reggiardo MV; Tanno F; Mendizabal M; Galdame O
    Acta Gastroenterol Latinoam; 2014 Jun; 44(2):154-73. PubMed ID: 25199310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.